期刊
TUMOR BIOLOGY
卷 36, 期 10, 页码 7987-7996出版社
SAGE PUBLICATIONS LTD
DOI: 10.1007/s13277-015-3426-y
关键词
MDSC; PD-L1; Esophageal squamous cell carcinoma; Prognostic marker
类别
资金
- National Natural Science Foundation of China [31300746, 81372276, 31320103918]
- Natural Science Foundation of Jiangsu [BK20131158]
- Natural Science Foundation of Suzhou [SYS201323]
Accumulating evidences demonstrate that a population of suppressive cells known as myeloid-derived suppressor cells (MDSCs) is key immune modulators which suppress antitumor immunity. In this study, we found that the level of circulating CD14(+)HLA-DR-/low cells in patients was significantly higher than that of healthy donors and was correlated with tumor burden, lymph node metastasis, and tumor, node, and metastasis (TNM) clinical stage. More importantly, we for the first time find the level of CD14(+)HLA-DR-/low is a biological indicator of poor prognosis through the analysis of 3-year overall survival. Furthermore, we evidenced that the proportion of CD14(+)HLA-DR-/low cells in the tumor metastatic tumor-draining lymph nodes (TDLNs) was notably higher compared to tumor-free TDLNs. Additionally, CD14(+)HLA-DR-/low cells from esophageal squamous cell carcinoma (ESCC) patients expressed dramatically increased programmed death ligand 1 (PD-L1) comparing to that from healthy control. Subsequently, blocking PD-L1 pathway by antibody could effectively reverse the suppressive effect on autologous T cell proliferation mediated by CD14(+)HLA-DR-/low cells in vitro. In conclusion, our data revealed CD14(+)HLA-DR-/low MDSCs which increase in ESCC patients is a novel poor prognostic indicator and may exert immunosuppressive properties through PD-L1/PD-1 pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据